Molecular Neurodegeneration Miscellaneous

This course provides an overview of the molecular basis of neurodegeneration

The programme will focus on several disorders including Alzheimer’s disease, Parkinson’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosisThere are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processesParticipants will gain an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies

The programme is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchersWe encourage applications from researchers based in the pharmaceutical and biotechnology industriesApplications from those who have completed a PhD in another area and have moved into neuroscience for their postdoctoral studies will also be considered

The course will benefit researchers who seek a comprehensive view of neurodegenerative disorders together with state of the art research techniques, and who wish to gain a new perspective on their own studiesThe intensive programme provides the opportunity to interact with leading international neuroscientistsTo optimize discussions and interactions, numbers are limited to 30 students

The programme is lecture-based but highly interactiveParticipants will have the opportunity to share their research with tutors, speakers and other students throughout the course, during the formal poster sessions and discussion sessions

Topics will include:
- Pathological events in neurodegeneration
- Autophagy, aging and neurodegeneration
- Genetic variation in inherited and sporadic disease
- Use of in vivo models to study neurological pathogenesis
- Modelling neurodegeneration using iPSCs
-Development of therapeutic approaches

Speakers: Scientific programme committee: Sue Ackerman (University of California, San Francisco, USA), Mark Cookson (National Institutes of Health, USA), Beverly Davidson (The Children’s Hospital of Philadelphia, USA), Harry Orr (University of Minnesota, USA), Nicholas Wood (University College London, UK)

Category: Conferences | Science, Health and Medicine | Biology

More details